0000895345-23-000577 Sample Contracts

IMMUNOME, INC.
Board Appointment Rights • October 12th, 2023 • Immunome Aggregator, LP • Pharmaceutical preparations • Delaware

Reference is hereby made to the subscription agreement, dated as of June 29, 2023 (the “Subscription Agreement”), by and between Immunome, Inc. (the “Company”), and Enavate Sciences, LP (the “Enavate Investor”). This letter agreement (this “Agreement”) is being delivered in connection with the purchase by the Enavate Investor of shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”) and the Enavate Investor’s entry into the Subscription Agreement. Capitalized terms used but not defined herein shall have the meanings set forth in the Subscription Agreement.

AutoNDA by SimpleDocs
JOINT FILING AGREEMENT
Joint Filing Agreement • October 12th, 2023 • Immunome Aggregator, LP • Pharmaceutical preparations

The undersigned hereby agree that a single Schedule 13D (and any amendment thereto) relating to the Common Stock of Immunome, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13D.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!